CA1 and neoplasm: With the increasing knowledge of the CAI mechanism of action, other classes of selective inhibitors have been developed exploiting different molecular properties, such as coumarin compounds and their bioisosteres, that show a strong selectivity towards the tumour-associated isoforms hCA IX and XII, being though less potent than primary sulphonamide derivatives14,.15